Latest News of IDXX
IDEXX Laboratories (NASDAQ:IDXX) Ticks All The Boxes When It Comes To Earnings Growth
By Yahoo! Finance |
5 days ago
Investors often seek 'the next big thing' in stocks, but investing in companies with profits like IDEXX Laboratories (NASDAQ:IDXX) can be a safer bet. With consistent revenue and profits, growth poten...
A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
By Yahoo! Finance |
1 week ago
IDEXX Laboratories' fair value estimate is 19% lower than the analyst price target of US$546. Using a Discounted Cash Flow model, the Total Equity Value is estimated at US$36b, indicating the company ...
IDEXX Laboratories' (NASDAQ:IDXX) five-year earnings growth trails the favorable shareholder returns
By Yahoo! Finance |
3 weeks ago
One way to grow wealth in the stock market is by investing in quality businesses at attractive prices. For instance, IDEXX Laboratories, Inc. (NASDAQ:IDXX) has shown steady growth in share price and e...
-
Here's Why IDEXX Laboratories (IDXX) Detracted in Q2
By Yahoo! Finance | 1 month agoBaron Funds' "Baron Partners Fund" Q2 2024 investor letter highlights its outperformance against the Russell Midcap Growth Index. The fund's top holding, IDEXX Laboratories, Inc. (IDXX), showed solid ...
-
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
By Yahoo! Finance | 2 months agoIDEXX Laboratories, Inc. has seen fluctuating stock prices recently, from highs of US$549 to lows of US$468. With a high price-to-earnings ratio above the industry average, the stock is currently cons...
-
Shareholders Are Optimistic That IDEXX Laboratories (NASDAQ:IDXX) Will Multiply In Value
By Yahoo! Finance | 2 months agoTo identify a potential multi-bagger, look for a business with increasing Return on Capital Employed (ROCE) and growing capital employed. IDEXX Laboratories stands out with a 47% ROCE, surpassing the ...
-
Should You Invest in IDEXX Laboratories (IDXX)?
By Yahoo! Finance | 2 months agoClearBridge Investments released its Q2 2024 investor letters for its Growth and Dividend Strategies. The Growth Strategy outperformed despite market challenges, shifting benchmark and name change. Th...
-
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 11% CAGR delivered to shareholders
By Yahoo! Finance | 3 months agoIDEXX Laboratories stock has risen 67% in the last five years, underperforming the market. Despite a recent 3.3% drop, the company's EPS growth of 18% annually suggests a positive long-term outlook fo...
-
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case
By Yahoo! Finance | 3 months agoInvesting in companies with potential to reverse fortunes may attract speculators, but caution is advised as losses can drain capital. IDEXX Laboratories stands out with consistent revenue and profit ...